title: [Individualized medicine. DNA tests for better treatment safety].
mesh_terms: D000928:Antidepressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D001711:Biotransformation / Q000235:genetics*; D000077144:Clopidogrel; D004305:Dose-Response Relationship, Drug; D005544:Forecasting; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D008657:Metabolic Clearance Rate / Q000235:genetics*; D057285:Precision Medicine / Q000639:trends*; D017422:Sequence Analysis, DNA; D013629:Tamoxifen / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D013629:Tamoxifen; D000077144:Clopidogrel; D013988:Ticlopidine